Skip to main content

Exploring New Treatment Advances for Acid Sphingomyelinase Deficiency in Adults

Tracking # 20-944359

Free

There are no ratings for this course

Learn more
Educator I3 HEALTH
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

In this activity, explore new treatment advances for acid sphingomyelinase deficiency (ASMD) in adults with Neal Weinreb, Voluntary Associate Professor for Human Genetics at the University of Miami, Miller School of Medicine. Learn about diagnosis, counseling points, and the recent approval of the first acid sphingomyelinase (ASM) enzyme replacement therapy, which presents the first opportunity to address the pathology underlying this condition. Start the activity now!

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Practitioner

1.25h Practice-Focused Continuing Education

Clinical Nurse Specialist

1.25h Practice-Focused Continuing Education

Licensed Practical Nurse

1.25h Practice-Focused Continuing Education

Registered Nurse

1.25h Practice-Focused Continuing Education

Registered Nurse Practitioner

1.25h Practice-Focused Continuing Education

Bahamas Medical Council

Medical Practitioner

1.25h Continuing Medical Education

Georgia Board of Nursing

Licensed Practical Nurse

1.25h General

Registered Professional Nurse

1.25h General

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1.25h Category I CME

Physician and Surgeon Compact License

1.25h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1.25h AMA Category I

Physician Assistant

1.25h AMA Category I

New Hampshire Board of Medicine

Physician

1.25h Category 1 Hours

New Mexico Board of Nursing

Certified Nurse Practitioner

1.25h Continuing education relevant to nursing practice

Clinical Nurse Specialist

1.25h Continuing education relevant to nursing practice

Licensed Practical Nurse

1.25h Continuing education relevant to the licensed practical nurse

Registered Nurse

1.25h Continuing education relevant to nursing practice

North Dakota Board of Nursing

Advanced Practice Registered Nurse

1.25h CE Related to Nursing Practice

Licensed Practical Nurse

1.25h CE Related to Nursing Practice

Registered Nurse

1.25h CE Related to Nursing Practice

South Carolina Board of Nursing

Advanced Practice Registered Nurse

1.25h General

Licensed Practical Nurse

1.25h General

Registered Nurse

1.25h General

Tennessee Board of Medical Examiners

Medical Doctor

1.25h AMA Category I CME

Disclosure statements

DISCLOSURE OF RELEVANT FINANCIAL INFORMATION WITH INELIGIBLE COMPANIES

i3 Health endorses the standards of the ACCME and ANCC that require everyone in a position to control the content of a CME/NCPD activity to disclose all financial relationships with ineligible companies that are related to the content of the CME/NCPD activity. CME/NCPD activities must be balanced, independent of commercial bias, and promote improvements or quality in health care. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when an individual has an opportunity to affect CME/NCPD content about products or services of a commercial interest with which he/she has a financial relationship, which therefore may bias their opinions and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks, or other financial benefits.

i3 Health will identify, review, and mitigate all relevant financial relationships that speakers, authors, or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. i3 Health does not endorse any products or services.

Relevant financial relationships exist between the following individuals and ineligible companies:

The i3 Health planners, reviewers, and managers have nothing to disclose.

Assuntina G. Sacco, MD, discloses that she has served on an advisory board or panel for Bicara, that she has served as a consultant for First Thought, and that she has received grants/research support from Bicara, Merck, and Nektar.

i3 Health has mitigated all relevant financial relationships.